Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Division of Pulmonary and Sleep, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pediatr Pulmonol. 2021 Nov;56(11):3464-3471. doi: 10.1002/ppul.25301. Epub 2021 Mar 17.
Respiratory disease is unfortunately common in preterm infants with the archetype being bronchopulmonary dysplasia (BPD). BPD affects approximately 50,000 preterm infants in the U.S. annually with substantial morbidity and mortality related to its pathology (alveolar, airway, and pulmonary vasculature maldevelopment). Predicting the likelihood and severity of chronic respiratory disease in these children as they age is difficult and compounded by the lack of consistent phenotyping. Barriers to understanding the actual scope of this problem include few longitudinal studies, information limited by small retrospective studies and the ever-changing landscape of therapies in the NICU that affect long-term respiratory outcomes. Thus, the true burden of adult respiratory disease caused by premature birth is currently unknown. Nevertheless, limited data suggest that a substantial percentage of children with a history of BPD have long-term respiratory symptoms and persistent airflow obstruction associated with altered lung function trajectories into adult life. Small airway disease with variable bronchodilator responsiveness, is the most common manifestation of lung dysfunction in adults with a history of BPD. The etiology of this is unclear however, developmental dysanapsis may underlie the airflow obstruction in some adults with a history of BPD. This type of flow limitation resembles that of aging adults with chronic obstructive lung disease with no history of smoking. It is also unclear whether lung function abnormalities in people with a history of BPD are static or if these individuals with BPD have a more accelerated decline in lung function as they age compared to controls. While some of the more significant mediators of lung function, such as tobacco smoke and respiratory infections have been identified, more work is necessary to identify the best means of preserving lung function for individuals born prematurely throughout their lifespan.
呼吸系统疾病在早产儿中很常见,其典型表现为支气管肺发育不良(BPD)。美国每年约有 5 万名早产儿患有 BPD,其病理(肺泡、气道和肺血管发育不良)与发病率和死亡率密切相关。随着这些儿童年龄的增长,预测其慢性呼吸系统疾病的可能性和严重程度具有一定难度,且由于缺乏一致的表型而变得更加复杂。由于缺乏纵向研究、受限于小样本回顾性研究的信息,以及新生儿重症监护病房中不断变化的治疗方法对长期呼吸结局的影响,因此,人们对这一问题的实际范围了解甚少。了解这一问题的障碍包括很少有纵向研究、受限于小样本回顾性研究的信息,以及新生儿重症监护病房中不断变化的治疗方法对长期呼吸结局的影响。因此,目前尚不清楚由早产引起的成人呼吸系统疾病的真正负担。然而,有限的数据表明,有相当一部分 BPD 患儿在成年后有长期的呼吸系统症状和持续性气流阻塞,这与肺功能轨迹的改变有关。小气道疾病伴可变的支气管扩张剂反应性,是 BPD 患儿中最常见的肺功能障碍表现。然而,其病因尚不清楚,在一些 BPD 患儿中,发育异常可能是气流阻塞的基础。这种类型的气流受限类似于没有吸烟史的慢性阻塞性肺病的成年患者。目前尚不清楚 BPD 患儿的肺功能异常是否是静态的,或者与对照组相比,这些 BPD 患儿随着年龄的增长,肺功能是否会加速下降。虽然已经确定了一些更重要的肺功能调节剂,如烟草烟雾和呼吸道感染,但仍需要更多的工作来确定在整个生命周期中保护早产儿肺功能的最佳方法。